Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Share News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Plethora droops on increased losses

Tue, 22nd Apr 2014 11:44

Shares in sexual health specialist Plethora Solutions drooped on news that the company made increased losses last year.On the upside, Plethora confirmed it has now settled on an "unambiguous defined path" for a successful submission for a US regulatory application for its lead product, 'PSD502', a treatment for premature ejaculation. During consultations, the US regulator confirmed that premature ejaculation was "an area of high medical need with a requirement for effective therapy" and recognised the importance of steps taken by Plethora towards this goal.However, the AIM-listed company lost £8.5m in the calendar year, up from £3.87m the year before.The losses were mainly from a £5.23m write-down in the value of warrants, together with a higher-than-usual £1.59m of central costs due to termination payments from the former Chief Executive and the restructuring of debt facilities. It said it has made "good progress" in negotiations with potential commercial partners in relation to a number of territories which will be responsible for the marketing distribution and sale of the treatment. Shares in Plethora were down 1.1% to 10.75p at midday on Tuesday.OH
More News
23 Dec 2015 09:39

Plethora Agrees GBP1.0 Million Loan Facility With Buyer Regent Pacific

Read more
22 Dec 2015 12:02

Port Erin Biopharma Continues To Look For Investments, Swings To Loss

Read more
15 Dec 2015 13:57

Plethora Solutions recommends GBP96m Regent Pacific offer

(ShareCast News) - Plethora Solutions, which is developing a treatment for premature ejaculation, has agreed on a takeover by Hong Kong-listed Regent Pacific that values the AIM company at roughly £96m or 11.65p per share. At Regent Pacific's closing price on Monday, this valued Plethora at a level

Read more
15 Dec 2015 13:47

Regent Pacific To Acquire Plethora Solutions For GBP114.3 Million

Read more
4 Nov 2015 12:19

LONDON MARKET MIDDAY: US Stocks Seen Up Ahead Of Data, Earnings

Read more
4 Nov 2015 10:32

Plethora Solutions Shares Soar, Agrees Regent Pacific Takeover Terms

Read more
4 Nov 2015 10:31

WINNERS & LOSERS SUMMARY: Housebuilders And Estate Agents Torn Down

Read more
28 Aug 2015 15:36

Plethora Interim Loss Narrows As Product Development Continues

Read more
5 Jun 2015 11:30

Plethora Ends Deal With Sharwood, Substitutes Deal With Regent Pacific

Read more
12 May 2015 08:43

Plethora Solutions Appoints New CFO, Non-Executive Director

Read more
30 Mar 2015 12:15

Port Erin Biopharma Swings To First Half Loss As Gains Do Not Recur

Read more
11 Nov 2014 10:48

Plethora Says Fortacin Prescription Sales May Hit USD1 Billion A Year

Read more
10 Nov 2014 09:50

Plethora Solutions Continues Progress Towards Launch Of Fortacin

Read more
7 Oct 2014 08:50

Plethora Solutions' Treatment To Be Marketed As Fortacin In EU

Read more
29 Sep 2014 13:40

Plethora Says Forest Nominees To Convert Loan Notes Into Shares (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.